Generated by All in One SEO v4.9.10, this is an llms.txt file, used by LLMs to index the site.

# 2bPrecise

## Sitemaps

- [XML Sitemap](https://www.2bprecise.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Dr. Joel Diamond Featured on Healthcare de Jure Podcast](https://www.2bprecise.com/dr-joel-diamond-featured-on-healthcare-de-jure-podcast/) - Host Matt Fisher talks to Dr. Joel Diamond, Chief Medical Officer at Aranscia, about defining genetics, genomics, and molecular testing; switching treatment from body area to specific genetic makeup; the connection to precision medicine and recognizing individual variations; defining pharmacogenetic testing and how to build it into workflows. Listen to the podcast here!
- [Top 8 Precision Medicine Companies in the USA](https://www.2bprecise.com/top-8-precision-medicine-companies-in-the-usa/) - Read More
- [InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow™ Ovarian Cancer Diagnostic Test](https://www.2bprecise.com/intervenn-biosciences-and-aranscia-expand-commercialization-partnership-for-glycoknow-ovarian-cancer-diagnostic-test/) - Aranscia’s Technology Platform to Accelerate InterVenn’s Research and Commercialization Initiatives SOUTH SAN FRANCISCO, Calif. and HOUSTON, June 30, 2026 /PRNewswire/ — InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology solutions, today announced an expansion
- [InterVenn Biosciences Partners with Aranscia to Accelerate Commercialization of GlycoKnow™ Non-Invasive Ovarian Cancer Diagnostic Test](https://www.2bprecise.com/intervenn-biosciences-partners-with-aranscia-to-accelerate-commercialization-of-glycoknow-non-invasive-ovarian-cancer-diagnostic-test/) - SOUTH SAN FRANCISCO & HOUSTON – January 7, 2026 InterVenn Biosciences, a precision diagnostics company advancing liquid biopsy with glycoproteomics, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology solutions, today announced a partnership where Aranscia technical and laboratory resources will help to facilitate clinical workflows and expand the availability of InterVenn’s flagship GlycoKnowTM Ovarian cancer diagnostic
- [Lessons from oncology drive precision medicine across clinical specialties](https://www.2bprecise.com/lessons-from-oncology-drive-precision-medicine-across-clinical-specialties/) - Read More
- [Precision Medicine Success: Begin with the End in Mind](https://www.2bprecise.com/precision-medicine-success-begin-with-the-end-in-mind/) - Read More
- [Meet the 9 Finalists of Calcalist’s Promising Startup Competition](https://www.2bprecise.com/meet-the-9-finalists-of-calcalists-promising-startup-competition/) - Read More
- [Geisinger Health and Sanford Health Ready to Offer Genetic Tests and Precision Medicine Services in Primary Care Clinics](https://www.2bprecise.com/geisinger-health-and-sanford-health-ready-to-offer-genetic-tests-and-precision-medicine-services-in-primary-care-clinics/) - Read More
- [DPYD Safety Update: Reducing the Risk of Critical or Fatal Chemotherapy Side Effects](https://www.2bprecise.com/dpyd-safety-update-reducing-the-risk-of-critical-or-fatal-chemotherapy-side-effects/) - Aranscia® solutions help oncologists comply with new FDA warning label requiring DPYD genetic testing in patients receiving select chemotherapies HOUSTON, Oct. 16, 2025 /PRNewswire/ -- Oncologists and pharmacy experts are reacting to last week's Food and Drug Administration warning that requires genetic testing on patients receiving the common chemotherapy drug capecitabine (Xeloda®) – and are actively seeking technologies
- [Digital health leaders share their views on what's to come in 2020](https://www.2bprecise.com/digital-health-leaders-share-their-views-on-whats-to-come-in-2020/) - Read More
- [2bPrecise and Murfreesboro Medical Clinic and SurgiCenter to Present at AMIA 2021 Clinical Informatics Conference on Pharmacogenomics](https://www.2bprecise.com/2bprecise-and-murfreesboro-medical-clinic-and-surgicenter-to-present-at-amia-2021-clinical-informatics-conference-on-pharmacogenomics/) - Leader in precision medicine solutions and multispecialty clinic customer to discuss the promise of genetic data at the point of care RALIEGH, NC – May 17, 2021 – 2bPrecise, a leader in precision medicine solutions, will present on the value of pharmacogenomics (PGx) at the AMIA 2021 Clinical Informatics Conference. The company will be joined
- [Cancer Screening Leaps Forward](https://www.2bprecise.com/cancer-screening-leaps-forward/) - Read More
- [Health IT Trends for 2019](https://www.2bprecise.com/health-it-trends-for-2019/) - Read More
- [Consumer Genetic Tests Accelerate Precision Medicine for Some Providers](https://www.2bprecise.com/consumer-genetic-tests-accelerate-precision-medicine-for-some-providers/) - Read More
- [AccessDX Holdings acquires 2bPrecise](https://www.2bprecise.com/accessdx-holdings-acquires-2bprecise/) - Combined capabilities create industry’s most advanced precision medicine enablement solution PITTSBURGH and HOUSTON – Aug. 25, 2021 – AccessDX Holdings, an international provider of advanced laboratory diagnostic solutions, has acquired 2bPrecise™ from Allscripts Healthcare Solutions. A recognized leader and innovator in healthcare informatics, 2bPrecise enables organizations to amplify their precision medicine strategies by delivering point-of-care
- [Vidence and 2bPrecise Announce Strategic Partnership to Unleash the Power of Genomic Data in Precision Oncology](https://www.2bprecise.com/vidence-and-2bprecise-announce-strategic-partnership-to-unleash-the-power-of-genomic-data-in-precision-oncology/) - Focus on providing Vidence Consortium Fellows with comprehensive genomic information and point-of-care tools to enhance clinical decision making, improve outcomes for oncology patients Boca Raton, FL and Raleigh, NC – October 27, 2020 – Vidence, an oncology informatics company, has selected the 2bPrecise™ platform, a precision medicine data delivery solution, to make it easier for
- [Spartanburg Regional Healthcare System (SRHS) Deploys 2bPrecise Enterprise](https://www.2bprecise.com/spartanburg-regional-healthcare-system-srhs-deploys-2bprecise-enterprise/) - Multi-year partnership affirms SRHS as a leader in precision care and genomics SPARTANBURG, S.C. and HOUSTON, June 25, 2025 /PRNewswire/ -- Spartanburg Regional Healthcare System (SRHS) today announced its deployment of the 2bPrecise® enterprise platform. Under this multi-year partnership, 2bPrecise-powered applications are now available across the SRHS care network, including a base of 700 physicians, six hospitals, and
- [Neurogen Biomarking Announces Partnership with Aranscia](https://www.2bprecise.com/neurogen-biomarking-announces-partnership-with-aranscia/) - Aranscia Diagnostic Laboratory and Technology Solutions Support Neurogen's Innovative Platform for the Early Detection of Mild Cognitive Impairment (MCI) and Alzheimer's Dementia CHICAGO and HOUSTON, May 21, 2025 /PRNewswire/ -- Neurogen Biomarking, the world's first ecosystem for memory loss with end-to-end patient support, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology
- [2bPrecise Exhibiting at PMWC 2025](https://www.2bprecise.com/2bprecise-exhibiting-at-pmwc-2025/) - 2bPrecise, alongside YouScript, is exhibiting at the upcoming 2025 Precision Medicine World Conference. The conference is taking place in Silicon Valley, CA on February 5-7. We invite attendees of the conference to meet our team at booth #A320 Schedule time with our team at PMWC by emailing connect@2bprecise.com.
- [PGx Biomarker Testing: Covered Soon for All Californians](https://www.2bprecise.com/pgx-biomarker-testing-covered-soon-for-all-californians/) - Good news for CA providers and residents! Starting July 1, 2024, Pharmacogenomic (PGx) biomarker testing will be a covered benefit for all Californians*, regardless of insurance provider. PGx testing is already a covered benefit for Medicare patients. Read the press release below, and learn more on the American Cancer Society's Cancer Action Network website. Read
- [2bPrecise Attending and Exhibiting at ViVE 2024](https://www.2bprecise.com/2bprecise-attending-and-exhibiting-at-vive-2024/) - 2bPrecise is excited to attend and exhibit at ViVE 2024, February 25-28 at the Los Angeles Convention Center in Los Angeles, CA.We invite attendees to stop by booth #2018 to learn about 2bPrecise’s innovative work in precision medicine and how it can benefit your organization.Want to schedule time with our team at ViVE? Email us
- [2bPrecise Education Series - "Precision Medicine: Your Secret to Competitive Excellence"](https://www.2bprecise.com/2bprecise-education-series-precision-medicine-your-secret-to-competitive-excellence/) - Precision Medicine: Your Secret to Competitive Excellence Join us for an enlightening webinar featuring Dr. William Feaster, MD, MBA, MJ, CHCIO, CDH-E, FCHIME, a highly accomplished clinician and healthcare executive with a remarkable career spanning anesthesia, ambulatory care, critical care, and clinical informatics. Dr. Feaster has not only contributed significantly to patient care but has also
- [2bPrecise Attending and Exhibiting at ViVE 2023](https://www.2bprecise.com/2bprecise-attending-and-exhibiting-at-vive-2023/) - 2bPrecise is excited to attend and exhibit at ViVE 2023, March 26th through 29th at the Music City Center in Nashville, TN. We invited attendees to stop by booth #2334 and learn about 2bPrecise's innovative work in precision medicine and how it can benefit your organization.
- [2bPrecise Named “Best Overall Genomics Company” in 2023 MedTech Breakthrough Awards Program](https://www.2bprecise.com/2bprecise-named-best-overall-genomics-company-in-2023-medtech-breakthrough/) - Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies [Houston, TX] – May 3, 2023 – 2bPrecise, a leading provider of transformative precision medicine solutions, today announced that it is the recipient of the “Best Overall Genomics Company” award in the 7th annual MedTech Breakthrough Awards. The
- [2bPrecise Named “Best Overall Genomics Company” in 2022 MedTech Breakthrough  Awards Program](https://www.2bprecise.com/2bprecise-named-best-overall-genomics-company-in-2022-medtech-breakthrough-awards-program/) - Prestigious Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies PITTSBURGH, PA, – May 5, 2022 – 2bPrecise, a leading provider of transformative precision medicine solutions, today announced that it has been selected as the winner of the “Best Overall Genomics Company” award in the sixth annual MedTech Breakthrough Awards Program. This
- [ViVE 2022](https://www.2bprecise.com/vive-2022/) - Miami Beach, March 6-9
- [HIMSS 2022](https://www.2bprecise.com/himss-2022/) - Orlando, March 14-18
- [PMWC International](https://www.2bprecise.com/pmwc-international/) - Silicon Valley, June 28-30
- [2bPrecise Joins the Epic App Orchard to Bring Its Precision Medicine Insights to the Point of Care](https://www.2bprecise.com/2bprecise-joins-the-epic-app-orchard-to-bring-its-precision-medicine-insights-to-the-point-of-care/) - Platform delivers genetic/genomic data directly into the EHR workflow for Epic customers Raleigh, NC – Nov. 3, 2021 - 2bPrecise™ announced its Precision Health™ platform is now available in the Epic App Orchard Gallery. The App Orchard program enables developers to integrate their healthcare IT solutions with the Epic electronic health record (EHR) using standards-based
- [US Orthopedic Alliance Selects 2bPrecise To Accelerate Precision Medicine Program](https://www.2bprecise.com/us-orthopedic-alliance-selects-2bprecise-to-accelerate-precision-medicine-program/) - Partnership will enable member orthopedic surgeons to identify potential drug-gene interactions to improve the patient experience and outcomes RALEIGH, N.C. and LAKE FOREST, Calif. – May 24, 2021 – US Orthopedic Alliance (USOA) has selected 2bPrecise to provide its precision medicine platform to USOA’s network of more than 100 orthopedic surgeons. The 2bPrecise pharmacogenomics module
- [KidsX Webinar Recording: Oh, Baby – Leveraging Precision Medicine at the Point of Care in Pediatrics and Neonatology](https://www.2bprecise.com/kidsx-webinar/) - Webinar: https://youtu.be/6XtHNlR50fQ
- [2bPrecise Deepens Oncology Functionality, Introduces Automation to Identify Medication Safety Risk in Polypharmacy Patients](https://www.2bprecise.com/2bprecise-deepens-oncology-functionality-introduces-automation-to-identify-medication-safety-risk-in-polypharmacy-patients/) - Summer 2021 product features customer-driven enhancements, including patient-directed family history documentation, and strengthens infrastructure for greater scalability RALIEGH, NC – July 27, 2021 – 2bPrecise, an EHR-agnostic, cloud-based precision medicine platform, announced it delivered advanced and innovative functionality to clients via its Summer 2021 Product Release. With market adoption of genetic and genomic testing accelerating,
- [2bPrecise Wins Second Consecutive "Best Overall Genomics Solution" Award in Annual MedTech Breakthrough Awards Program](https://www.2bprecise.com/2bprecise-wins-second-consecutive-best-overall-genomics-solution-award-in-annual-medtech-breakthrough-awards-program/) - Prestigious Award Recognizes Outstanding Health and Medical Technology Products and Companies RALEIGH, N.C., – May 11, 2021 – 2bPrecise, a leader in precision medicine solutions, today announced it has once again been selected as the winner of the “Best Overall Genomics Solution” award in the fifth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough,
- [2bPrecise Enhancements Deliver Deeper Oncology, Medication Safety Insights for Providers](https://www.2bprecise.com/2bprecise-enhancements-deliver-deeper-oncology-medication-safety-insights-for-providers/) - Winter 2021 release features advanced patient timeline to improve cancer care and analytics to identify patients at greatest risk for adverse drug reactions RALIEGH, NC – March 31, 2021 – 2bPrecise delivers advanced and innovative functionality to clients via its winter 2021 product release this month. Responding to rising market demands for improved access to
- [Hendrick Health Deploys 2bPrecise™ Precision Health™ Platform](https://www.2bprecise.com/hendrick-health-deploys-2bprecise-precision-health-platform/) - Texas provider to focus on oncology initially, then expand across specialties and care settings RALEIGH, NC, and ABILENE, TX – Dec. 16, 2020 – Hendrick Health will deploy the 2bPrecise platform as the foundation for its precision medicine program. The initial focus will be in cancer care, where a significant volume of genomic testing is
- [Handelsman Family Practice Implements 2bPrecise™ Pharmacogenomics](https://www.2bprecise.com/handelsman-family-practice-implements-2bprecise-pharmacogenomics/) - Pittsburgh physicians seek to improve medication safety, efficacy for patients RALIEGH, NC – December 3, 2020 – Handelsman Family Practice, which provides care to patients in southeast Pittsburgh, has implemented the 2bPrecise pharmacogenomics (PGx) solution. The solution makes patient genomic information available to providers at the point of care, so they can ensure medications they
- [San Francisco Otolaryngology Selects 2bPrecise](https://www.2bprecise.com/san-francisco-otolaryngology-selects-2bprecise/) - Leading Bay-area ENT group to launch precision medicine program, beginning with pharmacogenomics RALEIGH, NC—Nov. 11, 2020—San Francisco Otolaryngology has selected the 2bPrecise™ platform as the foundation for its precision medicine strategy, beginning with pharmacogenomics (PGx) and potentially expanding to additional genetic/genomic testing. According to Jacob Johnson, MD, president of the medical group, the practice’s initial
- [2bPrecise Releases V3.0 With Advanced Precision Oncology, Germline and Pharmacogenomic Capabilities](https://www.2bprecise.com/2bprecise-releases-v3-0-with-advanced-precision-oncology-germline-and-pharmacogenomic-capabilities/) - Key enhancements include point-of-care tools enabling oncologists to identify and act upon germline information uncovered during tumor profiling PITTSBURGH, PA – July 23, 2020 – The latest update to the 2bPrecise precision health platform includes functionality to help oncologists identify genetic factors indicating patient risk for secondary cancers, as well as elevated risks for the
- [2bPrecise wins industry innovation award](https://www.2bprecise.com/2bprecise-wins-industry-innovation-award/) - Fierce Healthcare honors the precision medicine platform for clinical information management capabilities Raleigh, NC, Sept. 16, 2020 – Fierce Healthcare released its annual Fierce Innovation Report this week, naming 2bPrecise the industry’s top clinical information management solution. The intent of the awards program, according to Fierce Healthcare, is to "showcase organizations that over the past
- [Telegenetics helps independents thrive in COVID-fueled environment](https://www.2bprecise.com/telegenetics-helps-independents-thrive-in-covid-fueled-environment/) - Read More
- [Righting Wrongs in Precision Oncology Today:  Incorporating Informatics to Avoid Missed Opportunities](https://www.2bprecise.com/righting-wrongs-in-precision-oncology-today-incorporating-informatics-to-avoid-missed-opportunities/) - Patients continue to pay the price for missed opportunities that could shorten the disease-burden timeline and improve outcomes.
- [Clinical Use Cases: Pharmacogenomic Results Within the EHR Workflow](https://www.2bprecise.com/clinical-use-cases-pharmacogenomic-results-within-the-ehr-workflow/) - Results realized by providers who have integrated pharmacogenomic (PGx) test results within their EHR workflows.
- [Maneuvering the Rising Cost of Cancer Care](https://www.2bprecise.com/maneuvering-the-rising-cost-of-cancer-care/) - Read More
- [Tech optimization: Unlocking the promise of precision medicine](https://www.2bprecise.com/tech-optimization-unlocking-the-promise-of-precision-medicine/) - Read More
- [Genetics are becoming part of the standard of care](https://www.2bprecise.com/genetics-are-becoming-part-of-the-standard-of-care/) - Read More
- [Tips to Improve the Understanding of Precision Medicine at the Executive Health Care Level](https://www.2bprecise.com/tips-to-improve-the-understanding-of-precision-medicine-at-the-executive-health-care-level/) - Read More
- [Precision Medicine Beyond Tumor Sequencing](https://www.2bprecise.com/precision-medicine-beyond-tumor-sequencing/) - Read More
- [HIMSS2020 Preview: Getting Health Data to Flow](https://www.2bprecise.com/himss2020-preview-getting-health-data-to-flow/) - Read More
- [The precision medicine revolution](https://www.2bprecise.com/the-precision-medicine-revolution/) - Read More
- [Informatics Supports Adoption Of Genetics And Genomics Across Clinical Areas](https://www.2bprecise.com/informatics-supports-adoption-of-genetics-and-genomics-across-clinical-areas/) - Read More
- [Scott Becker Interviews Dr. Joel Diamond, Chief Medical Officer at 2bPrecise](https://www.2bprecise.com/scott-becker-interviews-dr-joel-diamond-chief-medical-officer-at-2bprecise/) - Read More
- [Genetic Testing with Joel Diamond & Building Health Care Communities with Ken Rubin](https://www.2bprecise.com/genetic-testing-with-joel-diamond-building-health-care-communities-with-ken-rubin/) - Read More
- [Evaluating the Benefits and Challenges of Genomics in Healthcare](https://www.2bprecise.com/evaluating-the-benefits-and-challenges-of-genomics-in-healthcare/) - Read More
- [Better Medicine, Better Experience](https://www.2bprecise.com/better-medicine-better-experience/) - Read More
- [IT will be key to precision medicine’s success in 2020](https://www.2bprecise.com/it-will-be-key-to-precision-medicines-success-in-2020/) - Read More
- [Precise Medicine Infrastructure Critical for Healthcare Success in 2020](https://www.2bprecise.com/precise-medicine-infrastructure-critical-for-healthcare-success-in-2020/) - Read More
- [5 financial implications of precision medicine for physician practices](https://www.2bprecise.com/5-financial-implications-of-precision-medicine-for-physician-practices/) - Read More
- [Pitfalls and Preparation: Responding to the Growth of Consumer Genetic Testing](https://www.2bprecise.com/pitfalls-and-preparation-responding-to-the-growth-of-consumer-genetic-testing/) - Read More
- [How a Nashville-area clinic teamed up with Allscripts on precision medicine](https://www.2bprecise.com/how-a-nashville-area-clinic-teamed-up-with-allscripts-on-precision-medicine/) - Read More
- [Cancer Patients Have Limited Understanding of Genomic Test Results](https://www.2bprecise.com/cancer-patients-have-limited-understanding-of-genomic-test-results/) - Read More
- [Implementation best practices: The best approaches to precision medicine](https://www.2bprecise.com/implementation-best-practices-the-best-approaches-to-precision-medicine/) - Read More
- [2bPrecise Solution Wins 2020 MedTech Breakthrough Award](https://www.2bprecise.com/2bprecise-solution-wins-2020-medtech-breakthrough-award/) - Read More
- [2bPrecise honored as recipient of the 2020 Microsoft Health Innovation Awards](https://www.2bprecise.com/2bprecise-honored-as-recipient-of-the-2020-microsoft-health-innovation-awards/) - Read More
- [Genesys PHO Selects 2bPrecise to Optimize Patient Wellbeing](https://www.2bprecise.com/genesys-pho-selects-2bprecise-to-optimize-patient-wellbeing/) - Read More
- [Don’t lock genomic data into silos](https://www.2bprecise.com/news-item/) - READ MORE
- [Arizona hospital to deploy Allscripts' precision medicine platform](https://www.2bprecise.com/arizona-hospital-to-deploy-allscripts-precision-medicine-platform/) - Read More
- [Success with precision medicine: Key considerations](https://www.2bprecise.com/success-with-precision-medicine-key-considerations/) - Read More
- [Allscripts opens precision medicine program to employees](https://www.2bprecise.com/allscripts-opens-precision-medicine-program-to-employees/) - Read More
- [5 Forces Driving The Acceleration of Precision Medicine in 2019](https://www.2bprecise.com/5-forces-driving-the-acceleration-of-precision-medicine-in-2019/) - Read More
- [2019: Bringing the Power of Genomics to the Point of Care](https://www.2bprecise.com/2019-bringing-the-power-of-genomics-to-the-point-of-care/) - Read More
- [Precision medicine: We know there's a market, but who are the top vendors?](https://www.2bprecise.com/precision-medicine-we-know-theres-a-market-but-who-are-the-top-vendors/) - Read More
- [KLAS: 13 precision medicine vendors with high 'mindshare' among providers](https://www.2bprecise.com/klas-13-precision-medicine-vendors-with-high-mindshare-among-providers/) - Read More
- [Next-gen precision medicine: Consumerism, EHR integration, SMART on FHIR](https://www.2bprecise.com/next-gen-precision-medicine-consumerism-ehr-integration-smart-on-fhir/) - Read More
- [EHRs designed with clinicians in mind — 3 Qs with Allscripts' patient safety expert](https://www.2bprecise.com/ehrs-designed-with-clinicians-in-mind-3-qs-with-allscripts-patient-safety-expert/) - Read More
- [Allscripts, Cerner offer a glimpse at tech priorities in new earnings reports](https://www.2bprecise.com/allscripts-cerner-offer-a-glimpse-at-tech-priorities-in-new-earnings-reports/) - Read More
- [2019: Bringing the Power of Genomics to the Point of Care](https://www.2bprecise.com/2019-bringing-the-power-of-genomics-to-the-point-of-care-2/) - Read More
- [Practical applications for genomics-making data available to all providers at the point of care](https://www.2bprecise.com/practical-applications-for-genomics-making-data-available-to-all-providers-at-the-point-of-care/) - Read More
- [Hospitals must look beyond the EMR for precision medicine programs, KLAS finds](https://www.2bprecise.com/hospitals-must-look-beyond-the-emr-for-precision-medicine-programs-klas-finds/) - Read More
- [Effective Precision Medicine Requires Moving Beyond the EHR](https://www.2bprecise.com/effective-precision-medicine-requires-moving-beyond-the-ehr/) - Read More
- [The future of precision medicine: 4 Qs with 2bPrecise CMO Joel Diamond](https://www.2bprecise.com/the-future-of-precision-medicine-4-qs-with-2bprecise-cmo-joel-diamond/) - Read More
- [Informatics strategy key to precision medicine success](https://www.2bprecise.com/informatics-strategy-key-to-precision-medicine-success/) - Read More
- [Making Precision Medicine a Reality at Cleveland’s University Hospitals](https://www.2bprecise.com/making-precision-medicine-a-reality-at-clevelands-university-hospitals/) - Read More
- [Genomics Within the Clinical Workflow: A New Standard of Care](https://www.2bprecise.com/genomics-within-the-clinical-workflow-a-new-standard-of-care/) - Read More

## Pages

- [Home](https://www.2bprecise.com/) - The Power Of Precision Medicine In The Right Hands WHO'S SUCCEEDING? The New Standard of Care Genomics is fast becoming the new standard of care. Science makes it possible. Consumers demand it. Providers seek better outcomes. With the 2bPrecise™ precision health™ platform, providers deliver therapeutic value faster. While better managing healthcare costs. And improving patient
- [About 2bPrecise](https://www.2bprecise.com/about2bprecise/) - Who is 2bPrecise? Who is 2bPrecise? Founded in 2015, 2bPrecise was established to enable providers to leverage the value of genomic data at the point of care. With deep expertise in data models, complex ontologies and clinical integration, the 2bPrecise team created a cloud-based platform that can span extensive healthcare organizations to support their precision
- [Contact](https://www.2bprecise.com/contact/) - Contact Us Get In Touch We would love to learn more about your precision medicine strategy. Please share your contact information below, or reach out to us by calling 888-958-2298 or emailing Connect@2bPrecise.com. Please enable JavaScript in your browser to complete this form.Please enable JavaScript in your browser to complete this form.Name *FirstLastEmail *Phone *Company
- [Join the Team](https://www.2bprecise.com/join-the-team/) - Join The Team 2bPrecise Careers If you are interested in helping 2bPrecise accelerate dimensional change in health care, we invite you to review current job openings. 2bPrecise offers the energy of a start-up, with ample opportunities to impact the company’s direction and future. We are committed, first and foremost, to our clients. Bringing precision medicine
- [DPYD](https://www.2bprecise.com/dpyd/) - FDA Label Update for Xeloda® In October 2025, the Food and Drug Administration revised its warning label for the common chemotherapy drug, capecitabine (Xeloda®).The warning label now explicitly recommends that providers conduct pharmacogenomic testing (PGx) before beginning treatment. Why? Because certain DPYD genetic variants may cause some patients to experience critical or fatal side effects
- [Who's Succeeding?](https://www.2bprecise.com/who-is-succeeding/) - Who's Succeeding? PLATFORM USERS Genomics Is Redefining the Standard of Care Case in point: Intermountain Healthcare recently announced it would conduct genomic testing on all newly diagnosed cancer patients – joining other industry-leading systems (Memorial Sloan Kettering and Geisinger, to name a few) with similar policies.But a significant gap remains: While countless organizations are now
- [Enterprise Strategy](https://www.2bprecise.com/who-is-succeeding/enterprise-strategy/) - Enterprise Strategy PATIENT JOURNEY If The Ball Isn't In Play, The Game Can't Progress This simple sports analogy underscores a critical consideration for precision medicine success: if genomic information isn’t available – to all providers across the entire organization – they can’t use it to advance care for patients. Locking the information in specialty- or
- [News & Events](https://www.2bprecise.com/news-events/) - News & Events News Dr. Joel Diamond Featured on Healthcare de Jure Podcast July 28, 2026 InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow™ Ovarian Cancer Diagnostic Test June 30, 2026 InterVenn Biosciences Partners with Aranscia to Accelerate Commercialization of GlycoKnow™ Non-Invasive Ovarian Cancer Diagnostic Test January 7, 2026 DPYD Safety Update: Reducing the
- [Pharmacogenomics](https://www.2bprecise.com/who-is-succeeding/pharmacogenomics/) - Pharmacogenomics Many Organizations Launch Their Precision Medicine Initiatives With Pharmacogenomics. Why? 0 % 90% Of Patients Have A Genetic Variation Affecting Drug Response1 0 % 18% Of 4 Billion Prescriptions In The US Affected By Actionable Pharmacogenomics2 0 % 34% of adverse drug reactions caused by Drug-Gene interactions (rather than Drug-Drug interactions)3 Reducing Costs Of
- [How Do I Succeed?](https://www.2bprecise.com/how-do-i-succeed/) - How Do I Succeed? HOW IT WORKS In Short, Start With The End In Mind Healthcare leaders acknowledge genomics will change how they practice medicine. But getting from here to there seems overwhelming.The 2bPrecise platform enables your organization to get started in the clinical area that makes most sense for you – e.g., pharmacogenomics, cardiology,
- [About 2bPrecise](https://www.2bprecise.com/about-2bprecise/) - Who is 2bPrecise? Who is 2bPrecise? Founded in 2015, 2bPrecise was established to enable providers to leverage the value of genomic data at the point of care. With deep expertise in data models, complex ontologies and clinical integration, the 2bPrecise team created a cloud-based platform that can span extensive healthcare organizations to support their precision
- [Legal](https://www.2bprecise.com/legal/) - Legal Privacy Policy PRIVACY POLICYLast updated August 09, 2024This privacy notice for 2bPrecise Technologies LLC (doing business as 2bPrecise) (“we,” “us,” or “our“), describes how and why we might collect, store, use, and/or share (“process“) your information when you use our services (“Services“), such as when you:Visit our website at https://www.2bprecise.com, or any website of
- [Request A Demo](https://www.2bprecise.com/request-a-demo/) - Request A Demo Schedule Your Free Demo Today Please enable JavaScript in your browser to complete this form.Please enable JavaScript in your browser to complete this form.Name *FirstLastEmail *Phone *Company / Facility Name *AddressAddress Line 1Address Line 2City--- Select state ---AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingStateZip CodeNumber of
- [ViVE 2024 Sign-Up](https://www.2bprecise.com/vive2024signup/) - Sign Up Today Session Sign-Up Form Join 2bPrecise and Dr. William Feaster for a 20-minute session at booth #2018 to learn how CHOC, one of the nation's leading pediatric healthcare organizations, initiated a groundbreaking project to integrate their results from precision diagnostics providers with Cerner, supporting their oncology, neurology, and behavioral health programs.
- [Insider Access](https://www.2bprecise.com/insider-access-blog/) - Insider Access VIEW NEWS FEED A Finger On The Pulse Breakthroughs and innovations occur at a dizzying pace in precision medicine and genomics: Scientific discoveries. Research advances. Technology development. Clinical practice. And keeping current on precision medicine is just one of many disciplines impacting your professional success. Let us help. 2bPrecise has designated a team
- [Precision Oncology](https://www.2bprecise.com/who-is-succeeding/precision-oncology/) - Precision Oncology Trajectory of care Precision Oncology Is Making Headlines Headlines like this are becoming common:FDA approves ‘precision medicine’ drug for different cancers with same mutationWhat does it mean? That the most effective cancer treatment isn’t necessarily determined by tumor site – but by biomarkers and mutations found in an array of cancers.As more cancer
- [404 Error](https://www.2bprecise.com/404-error/) - Oops, Something Went Wrong...​ It appears the page you are looking for does not exist. Please check the URL and try again, or use our menu above to navigate to the page you’re searching for. VISIT HOMEPAGE
- [Thank you](https://www.2bprecise.com/thank-you/) - Thank You Thank you. Your form submission was received successfully. RETURN HOME
- [Team Thank You](https://www.2bprecise.com/team-thank-you/) - Thank You Thank you Your Intro copy here RETURN HOME

## leadership

- [Houda Hachad, PharmD, M. Res.](https://www.2bprecise.com/leadership/liat-goldberg-lead-scientist-2/) - Vice President of Clinical Operations
- [Eyal Greenberg](https://www.2bprecise.com/leadership/eyal-greenberg-vice-president-solutions-management/) - Vice President, Solutions Management
- [Joel Diamond, MD](https://www.2bprecise.com/leadership/joel-diamond-md-co-founder-chief-medical-officer/) - Co-Founder & Chief Medical Officer​
- [Assaf Halevy](https://www.2bprecise.com/leadership/assaf-halevy-founder-ceo/) - Founder & CEO
- [Liat Goldberg](https://www.2bprecise.com/leadership/liat-goldberg-lead-scientist/) - Lead Scientist

## Insider Access

- [Gaining momentum: Germline testing on all cancer patients](https://www.2bprecise.com/insider-access/gaining-momentum-germline-testing-on-all-cancer-patients/) - Intermountain Healthcare has joined a number of leading organizations that are leveraging genomic testing as a new standard of care for cancer patients. Read More
- [Gene mutation, not cancer site, drives treatment](https://www.2bprecise.com/insider-access/gene-mutation-not-cancer-site-drives-treatment/) - Underscoring the role genetics plays in cancer care, the FDA has approved a drug for a wide range of cancers based on a shared mutation, rather than the tumors' location – a win for those who recognize the impact precision medicine has on therapy and outcomes. Read More
- [PGx Reimbursement](https://www.2bprecise.com/insider-access/pgx-reimbursement/) - Because it’s such an evolving area of medicine, reimbursement for pharmacogenomic testing varies across the country – and impacts clinical decisions made on a daily basis. Take a look at IGNITE’s overview of which Medicare Administrative Contractor (MAC) serves each state and which genetic tests are covered by the MAC, as well as the associated
- [Lack of precision medicine strategy triggers legal ramifications](https://www.2bprecise.com/insider-access/lack-of-precision-medicine-strategy-triggers-legal-ramifications/) - Unconvinced about the impact genomic insights can have on your organization. A woman in the UK is suing her provider over non-disclosure of father’s Huntington’s disease. Read More
- [Accelerate precision medicine with Microsoft Genomics](https://www.2bprecise.com/insider-access/accelerate-precision-medicine-with-microsoft-genomics/) - A Microsoft Genomics white paper. Download

## Categories

- [News](https://www.2bprecise.com/category/news/)
- [Webinars](https://www.2bprecise.com/category/webinars/)
- [Pharmacogenomic](https://www.2bprecise.com/category/webinars/pharmacogenomic/)
- [Oncology](https://www.2bprecise.com/category/webinars/oncology/)
- [Events](https://www.2bprecise.com/category/events/)

## Tags

- [Genomics](https://www.2bprecise.com/tag/genomics/)
- [Oncology](https://www.2bprecise.com/tag/cancer/)
- [MedTech](https://www.2bprecise.com/tag/medtech/)
- [MedTech Breakthrough](https://www.2bprecise.com/tag/medtech-breakthrough/)
- [ViVE](https://www.2bprecise.com/tag/vive/)
- [ViVE 2023](https://www.2bprecise.com/tag/vive-2023/)
- [Event](https://www.2bprecise.com/tag/event/)
- [Conference Announcement](https://www.2bprecise.com/tag/conference-announcement/)
- [Dr. William Feaster](https://www.2bprecise.com/tag/dr-william-feaster/)
- [Precision Medicine](https://www.2bprecise.com/tag/precision-medicine/)
- [ViVE 2024](https://www.2bprecise.com/tag/vive-2024/)
- [California](https://www.2bprecise.com/tag/california/)
- [biomarker](https://www.2bprecise.com/tag/biomarker/)
- [Medi-Cal](https://www.2bprecise.com/tag/medi-cal/)
- [American Cancer Society Cancer Action Network](https://www.2bprecise.com/tag/american-cancer-society-cancer-action-network/)
- [ACS CAN](https://www.2bprecise.com/tag/acs-can/)
- [University of California](https://www.2bprecise.com/tag/university-of-california/)
- [pharmacogenomics](https://www.2bprecise.com/tag/pharmacogenomics/)
- [PGx](https://www.2bprecise.com/tag/pgx/)
- [Senate](https://www.2bprecise.com/tag/senate/)
- [SB 496](https://www.2bprecise.com/tag/sb-496/)
- [PMWC](https://www.2bprecise.com/tag/pmwc/)
- [PMWCINTL](https://www.2bprecise.com/tag/pmwcintl/)
- [Aranscia](https://www.2bprecise.com/tag/aranscia/)
- [Neurogen Biomarking](https://www.2bprecise.com/tag/neurogen-biomarking/)
- [Alzheimer's Disease](https://www.2bprecise.com/tag/alzheimers-disease/)
- [Spartanburg](https://www.2bprecise.com/tag/spartanburg/)
- [SRHS](https://www.2bprecise.com/tag/srhs/)
- [chemotherapy](https://www.2bprecise.com/tag/chemotherapy/)
- [DPYD](https://www.2bprecise.com/tag/dpyd/)
- [FDA](https://www.2bprecise.com/tag/fda/)
- [InterVenn Biosciences](https://www.2bprecise.com/tag/intervenn-biosciences/)
- [Ovarian Cancer](https://www.2bprecise.com/tag/ovarian-cancer/)
- [Press Release](https://www.2bprecise.com/tag/press-release/)
- [PrecisionMedicine](https://www.2bprecise.com/tag/precisionmedicine/)
- [Genetics](https://www.2bprecise.com/tag/genetics/)
- [MolecularTesting](https://www.2bprecise.com/tag/moleculartesting/)
- [PharmacogeneticTesting](https://www.2bprecise.com/tag/pharmacogenetictesting/)
- [PersonalizedMedicine](https://www.2bprecise.com/tag/personalizedmedicine/)
- [HealthcareInnovation](https://www.2bprecise.com/tag/healthcareinnovation/)
- [ClinicalWorkflows](https://www.2bprecise.com/tag/clinicalworkflows/)
- [GenomicMedicine](https://www.2bprecise.com/tag/genomicmedicine/)
- [DigitalHealth](https://www.2bprecise.com/tag/digitalhealth/)
- [HealthcareTechnology](https://www.2bprecise.com/tag/healthcaretechnology/)
- [PrecisionHealth](https://www.2bprecise.com/tag/precisionhealth/)
- [MedicalGenetics](https://www.2bprecise.com/tag/medicalgenetics/)
- [HealthcarePodcast](https://www.2bprecise.com/tag/healthcarepodcast/)